SB 3104 Hawaii Senate · 2018 Regular Session

RELATING TO PHARMACY BENEFIT MANAGERS.

Summary

Establishes requirements for pharmacy benefit managers and maximum allowable cost, including the ability of pharmacies to receive comprehensive maximum allowable cost lists and bring complaints within the purview of the Department of Commerce and Consumer Affairs, rather than the Department of Health. Requires pharmacy benefit managers to disclose where an equivalent drug can be obtained at or below the maximum allowable cost when a maximum allowable cost is upheld on appeal. Allows contracting pharmacies to reverse and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost that is denied on appeal and is required to pay the difference to the contracting pharmacies. Preserves the prohibition of a contracting pharmacy from disclosing the maximum allowable cost list and related information to any third party. (SB3104 HD1)

Bill status passed both 4 of 5 stages cleared

Introduction

Jan 2018

Committee Review

Apr 2018

Senate Passage

Mar 2018

House Passage

Apr 2018

Governor

Introduced Jan 24, 2018 Last action Apr 26, 2018

Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Apr 26, 2018

Senate · Reported by committee

Conference committee meeting to reconvene on 04-27-18 9:00AM in conference room 229.

Apr 25, 2018

Senate · Reported by committee

Conference committee meeting to reconvene on 04-26-18 9:00AM in conference room 229.

Apr 24, 2018

Senate · Reported by committee

Conference committee meeting to reconvene on 04-25-18 9:00AM in conference room 229.

Apr 23, 2018

Senate · Reported by committee

Conference committee meeting to reconvene on 04-24-18 9:00AM in conference room 229.

Apr 20, 2018

Senate · Reported by committee

Conference committee meeting scheduled for 04-23-18 9:00AM in conference room 229.

Apr 10, 2018

Senate · Amendment offered

Senate disagrees with House amendments.

Apr 10, 2018

Senate · Introduced

Received from House (Hse. Com. No. 545).

Apr 6, 2018

House · Passed

Passed Third Reading with none voting aye with reservations; none voting no (0) and Representative(s) Holt excused (1). Transmitted to Senate.

Apr 3, 2018

House · Reported by committee

The committees on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 12 Ayes: Representative(s) Luke, Cullen, Cachola, DeCoite, Gates, Holt, Keohokalole, Kobayashi, Lowen, Nakamura, Todd, Yamashita; Ayes with reservations: none; 0 Noes: none; and 3 Excused: Representative(s) Fukumoto, Tupola, Ward.

Mar 23, 2018

House · Referred to committee

Report adopted. referred to the committee(s) on FIN as amended in HD 2 with none voting aye with reservations; none voting no (0) and Representative(s) C. Lee, Lowen, McDermott, Souki, Tokioka excused (5).

Mar 23, 2018

House · Referred to committee

Reported from CPC (Stand. Com. Rep. No. 1453-18) as amended in HD 2, recommending referral to FIN.

Mar 21, 2018

House · Reported by committee

The committees on CPC recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Takumi, Ichiyama, Aquino, Ito, Tokioka, Yamane, McDermott; Ayes with reservations: Representative(s) Say; Noes: none; and 3 Excused: Representative(s) Johanson, LoPresti, Mizuno.

Mar 16, 2018

House · Referred to committee

Reported from HHS (Stand. Com. Rep. No. 1205-18) as amended in HD 1, recommending passage on Second Reading and referral to CPC.

Mar 14, 2018

House · Reported by committee

The committees on HHS recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 3 Ayes: Representative(s) Mizuno, Kobayashi, Learmont; Ayes with reservations: none; Noes: none; and 2 Excused: Representative(s) Belatti, Tupola.

Mar 13, 2018

House · Reported by committee

The committee(s) on HHS recommend(s) that the measure be deferred until 03-14-18 10:00 AM in room 329.

Mar 8, 2018

House · Referred to committee

Referred to HHS, CPC, FIN, referral sheet 35

Mar 6, 2018

House · Introduced

Received from Senate (Sen. Com. No. 421) in amended form (SD 2).

Mar 6, 2018

Senate · Passed

Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

Feb 23, 2018

Senate · Reported by committee

The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in WAM were as follows: 10 Aye(s): Senator(s) Dela Cruz, Keith-Agaran, English, Galuteria, Harimoto, Inouye, K. Kahele, Kidani, Riviere, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Shimabukuro.

Feb 20, 2018

Senate · Reported by committee

The committee(s) on WAM will hold a public decision making on 02-23-18 11:00AM in conference room 211.

Feb 16, 2018

Senate · Referred to committee

Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.

Feb 16, 2018

Senate · Referred to committee

Reported from CPH (Stand. Com. Rep. No. 2484) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

Feb 6, 2018

Senate · Reported by committee

The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, S. Chang, Espero, Ihara, Ruderman; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Tokuda, Nishihara.

Jan 31, 2018

Senate · Reported by committee

The committee(s) on CPH has scheduled a public hearing on 02-06-18 9:00AM in conference room 229.

Jan 26, 2018

Senate · Referred to committee

Referred to CPH, WAM.

Jan 24, 2018

Senate · Introduced

Introduced.

9 primary · 0 co-sponsors